Stay updated on Impact of BAY1817080 on Rosuvastatin Pharmacokinetics Clinical Trial
Sign up to get notified when there's something new on the Impact of BAY1817080 on Rosuvastatin Pharmacokinetics Clinical Trial page.

Latest updates to the Impact of BAY1817080 on Rosuvastatin Pharmacokinetics Clinical Trial page
- Check7 days agoChange DetectedAdded Revision: v3.4.2 and removed the older government-funding notice (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center operations was added, and the page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a glossary toggle and new footer metadata (Last Update Submitted that Met QC Criteria, Revision: v3.4.0); removed the prior QC wording, No FEAR Act data note, and the older Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. This appears to be a superficial metadata change that does not modify study details or displayed content.SummaryDifference0.1%

- Check64 days agoChange DetectedA dedicated Locations section now lists Daytona Beach, Florida as the study site, replacing the previous Florida Locations label. The HHS Vulnerability Disclosure link in the footer was removed.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page's revision tag was updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Impact of BAY1817080 on Rosuvastatin Pharmacokinetics Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Impact of BAY1817080 on Rosuvastatin Pharmacokinetics Clinical Trial page.